Ann: Phase 2 PTSD Clinical Trial Fully Recruited, page-5

Treatment period is three months.

Collation of data is ongoing.

Analysis of results - perrhaps a month???

Results August/September - theoretically.

If results are bad, then they will try and re-interpret with positive spin and release may take longer.

If results are clearly positive, then they will want them out pronto.

Just my observations - you be the judge.

GLTA.

P.S. I personally would have expected a bit more of a bump in the share price as this really does start the clock ticking on the release of PTSD results and anyone who wants to be there when they come out has maybe 4 months to get set.

The announcement of oncology assets sale for a "good" up-front amount plus milestones and royalties is supposedly due before 30th June. If mooted numbers exceed expectations, then the cost of getting set ahead of PTSD readout could increase materially.